Product Images Moxifloxacin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Moxifloxacin NDC 68180-422 by Lupin Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

074e7497 9c60 4050 bfd9 288bd169fae3 01

074e7497 9c60 4050 bfd9 288bd169fae3 01

074e7497 9c60 4050 bfd9 288bd169fae3 02

074e7497 9c60 4050 bfd9 288bd169fae3 02

This is a description of a prescription drug with the NDC code 68180-422-01. The drug contains Moxifloxacin hydrochloride USP 5.45 mg per mL of solution, ophthalmic equivalent to moxifloxacin 5 mg g. It is manufactured by an entity called Lupin and is intended for use in the eyes only. The solution is sterile and the product comes in a 3mL package with an expiration date of 28/6/2010.*

074e7497 9c60 4050 bfd9 288bd169fae3 03

074e7497 9c60 4050 bfd9 288bd169fae3 03

This is a product description for Moxifloxacin Ophthalmic Solution, USP, used for eye treatment. One mL of the solution contains 5.45 mg of moxifloxacin hydrochloride USP, which is equivalent to 5mg of Moxifloxacin. The solution also has inactive ingredients such as borle acld, sodlum chlorids, and water for injection that may contain hydrochlorlc acld and/or sodium hydroxide to alter pH. The product, manufactured by Lupin Limited, is for use in eyes only and is sterile. The recommended dosage is one drop in the affected eye three times a day for seven days, as prescribed. The product should be stored at 2°C to 25°C (36°FW77°F), and needs to be kept out of reach of children.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.